Shanghai, China

Yiqian Chen

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yiqian Chen: Innovator in Pharmaceutical Chemistry

Introduction

Yiqian Chen is a prominent inventor based in Shanghai, China, known for his significant contributions to pharmaceutical chemistry. With a total of four patents to his name, he has made strides in developing therapeutic agents that target specific medical needs.

Latest Patents

Among his latest patents is a pyridopyrimidine derivative, which includes a preparation method and its medical use. This derivative is particularly noted for its role as a TLR8 agonist, showcasing its potential as a therapeutic agent. Another notable patent involves the pharmaceutically acceptable salts of bicyclo-substituted pyrazolon azo derivatives. This patent details their preparation methods, pharmaceutical compositions, and their use as thrombopoietin mimetics, emphasizing their role as agonists of the thrombopoietin receptor.

Career Highlights

Yiqian Chen has worked with reputable companies in the pharmaceutical industry, including Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His work in these organizations has allowed him to contribute to the advancement of medical science through innovative drug development.

Collaborations

Throughout his career, Yiqian has collaborated with notable colleagues, including Peng Cho Tang and Hejun Lü. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Yiqian Chen's work exemplifies the impact of innovation in the pharmaceutical field. His patents and collaborations highlight his commitment to advancing medical science through effective therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…